Back to Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 1

Review

Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec®, Gleevec™)

       
Total article views   HTML views PDF downloads Totals
6,710 Dovepress* 6,710+ 2,698 9,408
Totals 6,710 2,698 9,408
*Since 8 February 2008
+Since July 2016

View citations on Google Scholar